共 12 条
[1]
ATP-sensitive K+ channel openers:old drugs with new clinical benefits for the heart. Miura T,Miki T. Curr Vase Pharmacol . 2003
[2]
Use of nicorandil in cardiovascular disease and itsoptimization. Horinaka S. Drugs . 2011
[3]
Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Tsang A,Hausenloy DJ,Mocanu MM,et al. Circulation Research . 2004
[4]
Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Sun HY,Wang NP,Kerendi F,et al. American Journal of Physiology Heart and Circulatory Physiology . 2005
[6]
Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. Ahmed LA,Salem HA,Attia AS, et al. European Journal of Pharmacology . 2011
[7]
Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats[J] . Lamiaa A. Ahmed,Hesham A. Salem,Amina S. Attia,Azza M. Agha.  European Journal of Pharmacology . 2011 (1)
[9]
What is theoptimal postconditioning algorithm?. Iliodromitis EK,Downey JM,Heusch G,et al. J Cardiovasc Pharma-col Ther . 2009
[10]
Catecholamine cardiotoxicity. Rona G. Journal of Molecular and Cellular Cardiology . 1985